Advanced Cardiovascular Risk Assessment.

Comprehensive prevention requires a structured framework.

Schedule Consultation

Comprehensive clinical evaluation.

A detailed history and systematic review of past diagnostics establish an accurate clinical baseline. Emphasizes prior imaging, stress testing, rhythm monitoring, and family history of inherited cardiovascular risk.

Metabolic and hematologic assessment.

Laboratory evaluation includes CBC, iron studies, B12, folate, renal function, A1C, lipid profile, lipoprotein(a), apolipoprotein B, and hsCRP—all integrated within clinical context.

Multimodal imaging & vascular assessment.

Coronary calcium scoring, echocardiography, carotid and venous duplex evaluation, and abdominal imaging provide objective measurement of atherosclerotic and vascular burden. Risk modeling incorporates conventional 10-year estimates as well as extended-horizon frameworks such as the PREVENT 30-year cardiovascular risk model.

Precision risk modeling.

Emerging biologic tools allow deeper refinement of cardiovascular risk and therapeutic strategy.

Genomic evaluation may include polygenic risk scoring to assess inherited susceptibility to atherosclerotic disease. While genetic predisposition does not determine outcome, it can inform earlier intervention and more individualized lipid-lowering thresholds.

Proteomic profiling offers additional insight into inflammatory activation, endothelial function, and plaque biology. When interpreted within clinical context, these biomarkers may further refine long-term risk estimation.

Importantly, genomic and proteomic data are not applied in isolation. They are integrated with imaging findings, lipid biomarkers, metabolic parameters, and family history to inform a structured prevention strategy.

Men’s cardiovascular health.

Cardiovascular risk in men frequently intersects with metabolic dysfunction, hormonal balance, and long-term vascular integrity. Structured evaluation may include metabolic syndrome assessment, lipid optimization, prostate-specific antigen (PSA) screening when appropriate, and integration of cardiovascular and endocrine risk factors.

The objective is disciplined, evidence-based management of cardiometabolic health within a long-horizon prevention strategy, emphasizing vascular longevity rather than isolated symptom management.

Expert review & testimony.

In addition to preventive cardiology services, Dr. Marmur provides expert cardiovascular case review involving risk stratification, imaging interpretation, and standards of care in interventional cardiology.

Services may include structured record review, written medical opinions, deposition testimony, and trial consultation. Engagements are approached with analytical rigor and adherence to evidence-based principles.

Schedule a consultation.

Begin advanced, evidence-based cardiovascular prevention today.

Schedule Consultation

Practice

Home

About

Our Team

Care

Services

Patient Info

FAQs

Contact

Location

Appointments

Resources

Insurance

Terms

Facebook

Instagram